ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Q&A: Navigating PFAS In Medical Devices

  Explore how PFAS in medical devices pose environmental and health concerns, prompting regulatory scrutiny.

• Rational Design Of Oral Nanosuspensions For Insoluble Drugs

  The advantages of nanosuspension dosage forms include improving bioavailability and API stability, increasing drug loading, better dose flexibility and accuracy, and easy swallowing for pediatric or geriatric populations.

• A Lifecycle Management Strategy For Sterile Injectables

  Gain insight into the benefits and challenges of transferring a therapeutic compound from one aseptic injectable format to another.

• Selecting An Alternative Coating Technology To Silicone Oil For Prefillable Syringes

  The challenges of silicone-oil lubrication and the growing trend for more viscous, protein-based drugs are now leading pharma and biotech companies to investigate alternative solutions.

• Evolution Of Novel Polymers To Overcome Limits In Sustained Drug Delivery

  Degradable polymers evolved from aliphatic polyesters to nitrogen-bearing biomaterials such as polyurethanes and polyester amides. Explore a brief history of the development of PEA polymers.

• Crystallization Process Dev: Ramping Up Bench-Scale Control

  Since physical structure and biological activity are directly linked, controlling the physical form of a compound is paramount to a final drug product’s quality and effectiveness.

• Achieving New Heights By Expanding Services, Talent, And Facilities

  As you aim to reduce costs and ensure on-time delivery, discover the opportunities for drug formulation and commercial supply that can advance your therapy to the clinic and beyond.

• Precision Powder-In-Capsule Micro-Dosing Accelerates Drug Development

  Precision powder microdosing makes it possible to quickly get formulations to the clinic, saving time, money, and use of limited APIs.

• A Step Change In Pharmaceutical Glass Packaging Innovation

  Valor Glass represents a significant, and much needed, step forward for glass innovation. Review the findings and learn how an aluminosilicate formulation can lower your glass vials' extractables profile.

• Harness High-Quality PBPK Modeling To Enhance Clinical Readiness

  Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.